Who backs Solu Therapeutics?
11 investors| Investor | Type |
|---|---|
| Alexandria Venture Investments | Other |
| DCVC Bio | Venture capital |
| Astellas Venture Management | Other |
| Biovision Ventures | — |
| Eli Lilly | — |
| Hengdian Group Capital (HgC) | — |
| Leukemia & Lymphoma Society | — |
| Longwood Fund | — |
| Pappas Capital | — |
| Santé Ventures | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Solu Therapeutics investors
11 investors are on record for Solu Therapeutics, including Alexandria Venture Investments, DCVC Bio, Astellas Venture Management and Biovision Ventures.
Free account
More of Solu Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Solu Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Solu Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View